Agreements reached under this partnership
Business Alliances- 1
We will provide Polyphron with high-quality human iPS cells from a diverse range of donors.
- 2
Polyphron will use its proprietary artificial human biology platform to generate longitudinal biological data using the iPS cells we provide.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Although the impact of this matter on our results for the current fiscal year is expected to be immaterial at this time, we believe it will make a significant contribution to our further growth and the sustainable enhancement of corporate value over the medium to long term.
| Item | Details |
|---|---|
| Name of alliance partner | Polyphron, Inc. |
| Alliance partner's business activities | Polyphron combines automated tissue manufacturing with AI simulation to create a physical and simulated validation platform for therapeutic hypotheses concerning living human biology. |
| Alliance partner's location | New York State, United States |
| Type of alliance | Business Alliances |
| Details of the alliance | We will provide Polyphron with high-quality human iPS cells from a diverse range of donors., Polyphron will use its proprietary artificial human biology platform to generate longitudinal biological data using the iPS cells we provide. |
| Impact on Business Performance | Although the impact of this matter on our results for the current fiscal year is expected to be immaterial at this time, we believe it will make a significant contribution to our further growth and the sustainable enhancement of corporate value over the medium to long term. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because our iPS cell technology can provide an important resource that reflects human biological diversity. Through the collaboration, we aim to support the generation of high-quality human tissue data for model training and evaluation, drug discovery and safety assessment.